ROUNDTABLE Global Perspectives: Understanding Challenges to Clinical Adoption
Friday, June 2, 2023 09:15 AM - 10:15 AM
Room 251
Roundtable
How do we ensure advanced therapies will reach patients globally, and who will be responsible for it?
Moderators
Miguel Forte, MD, PhD, President-Elect ISCT; CEO Kiji Tx; EiR AdBio - Kiji Tx/AdBio Partners
Sven Kili, MBChB, MRCS (Eng), CEO, Antion Biosciences SA, UK
Panelists
Maroun Khoury, PhD, CSO, Cells for Cells, Universidad de los Andes, Chilean Consortium for Regenerative Medicine, IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Chile
Eric Faulkner PhD, MPH, National Academy of Managed Care Physicians, USA
Jaap Jan Boelens, MD, PhD, Chief, Transplant and Cellular Therapies, Memorial Sloan Kettering Cancer Center, USA
Learning Objectives
Moderators
Miguel Forte, MD, PhD, President-Elect ISCT; CEO Kiji Tx; EiR AdBio - Kiji Tx/AdBio Partners
Sven Kili, MBChB, MRCS (Eng), CEO, Antion Biosciences SA, UK
Panelists
Maroun Khoury, PhD, CSO, Cells for Cells, Universidad de los Andes, Chilean Consortium for Regenerative Medicine, IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Chile
Eric Faulkner PhD, MPH, National Academy of Managed Care Physicians, USA
Jaap Jan Boelens, MD, PhD, Chief, Transplant and Cellular Therapies, Memorial Sloan Kettering Cancer Center, USA
Learning Objectives
- Address economic challenges for the adoption of advanced therapies that are specific to the US, to Europe, and to the rest of the world.
- Identify actors that have a role and responsibility in tackling these challenges.
- Discuss potential solutions at local, state, and international level.